Animalcare and YUN Announce Strategic Partnership to Lead Dermatological Innovation in Veterinary Medicine
Animalcare Group plc, a leading European veterinary pharmaceutical company, and YUN, a Belgian biotech innovator in the field of probiotics, have announced a strategic alliance to accelerate the development and commercialisation of microbiome-based veterinary products. This partnership positions Animalcare at the forefront of veterinary microbiome innovation, with a portfolio spanning gastrointestinal, dermatological, and otic health.
Advancing One Health Through Microbiome Science
In line with the global One Health strategy, which recognises the deep interconnection between human, animal, and environmental health, both companies are committed to offering innovative, responsible solutions in veterinary care. International health authorities such as the World Health Organisation (WHO), Food and Agriculture Organisation of the United Nations (FAO), and World Organisation for Animal Health (WOAH) emphasise the urgent need to reduce antibiotic use and encourage alternatives that support long-term health and wellbeing.
Probiotherapy seeks to restore the natural microbial balance of the skin, gut, or ears. By reinforcing the body’s own defences through beneficial bacteria, probiotic-based products offer a safe, science-backed approach that supports animal health whilst mitigating antimicrobial resistance (AMR).
“This alliance with YUN strengthens our commitment to microbiome science as a foundation for the future of veterinary medicine,” said Jenny Winter, CEO of Animalcare Group. “By helping to rebalance the microbiome, we can offer more natural, sustainable solutions that align with One Health goals and veterinary needs.”
Combining Human Expertise and Veterinary Reach
YUN has over a decade of academic research and clinical development in human probiotherapy. Its patented encapsulation technology protects live bacteria, ensuring they remain viable and effective where they are most needed, on the skin, in the mouth, or in mucosal environments.
This breakthrough technology, already applied in dermatological, oral and intimate human care, will now be translated into veterinary use under the Animalcare portfolio.
“We are pleased to be partnering with Animalcare which will allow us to advance animal health by bringing our expertise to this important sector.” said Tom Verlinden, CEO of YUN. “Our probiotic solutions are designed to help rebalance the microbiome, supporting the body’s natural ability to heal. Together, we can extend that benefit to pets in need.”
A New Standard in Veterinary Probiotics
This strategic partnership consolidates Animalcare’s leadership in the microbiome by combining its established gastrointestinal portfolio with YUN’s innovative solutions for skin and ear health. Together, the combined range now covers three essential areas in veterinary medicine:
- Gastrointestinal health – proGlan®, an advanced formulation designed to support the digestive microbiome and anal gland function in dogs.
- Dermatology – proAtop®, a probiotic skin spray for dogs, formulated with live Lactobacillus to help rebalance and support the skin microbiome in dogs prone to itching and irritation associated with sensitive skin
- Otic health – proAuris®, probiotic ear drops for dogs, containing live Lactobacillus to support the rebalancing and support of the ear microbiome, especially in cases of bacterial overgrowth or following antimicrobial treatment.
María Lasagabaster, Chief Operating Officer at Animalcare, commented: “Skin and ear conditions remain among the most common reasons for veterinary visits. Being able to offer an alternative that supports the balance of the microbiome gives veterinarians a new tool to help manage these frequent challenges effectively and more sustainably. This partnership reinforces our mission to deliver meaningful, science-based solutions to our customers.”
The initial launches of these products were successfully completed in the first half of 2025 across all European markets where Animalcare has a direct presence. The rollout was supported by tailored veterinary training, scientific communications, and targeted marketing campaigns adapted to each local market. These efforts have been met with a highly positive response from veterinarians across all regions.
